TREATMENT OF BENIGN PROSTATIC HYPERTROPHY WITH HYDROXYPROGESTERONE CAPROATE: EFFECT ON CLINICAL SYMPTOMS, MORPHOLOGY, AND ENDOCRINE FUNCTION.
D000077713:17 alpha-Hydroxyprogesterone Caproate; D001706:Biopsy; D004358:Drug Therapy; D006062:Gonadotropins; D006065:Gonadotropins, Pituitary; D006801:Humans; D006908:Hydroxyprogesterones; D007986:Luteinizing Hormone; D008297:Male; D010336:Pathology; D010902:Pituitary Gland; D011470:Prostatic Hyperplasia; D014556:Urine
D006062:Gonadotropins; D006065:Gonadotropins, Pituitary; D006908:Hydroxyprogesterones; D000077713:17 alpha-Hydroxyprogesterone Caproate; D007986:Luteinizing Hormone
BIOPSY; DRUG THERAPY; GONADOTROPINS, PITUITARY; HYDROXYPROGESTERONE; LH; PATHOLOGY; PROSTATIC HYPERTROPHY; URINE